购物车
0
有库存
HIT212658580
 sdf 文件
结构编辑
类似物检索
HIT212658580
  • HIT ID:HIT212658580
  • Cas No:494753-69-4
  • 常用名:Ginsenoside Rk1
  • 别名:人参皂苷RK1, 人参皂苷
  • IUPAC:(2S,3R,4S,5S,6R)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
    IUPAC:(2S,3R,4S,5S,6R)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
  • InChI key:KWDWBAISZWOAHD-MHOSXIPRSA-N
  • 分子式:C42H70O12
  • 分子量:767.01
  • 氢键供体数 (HBD):8
  • 氢键受体数 (HBA):12
  • LogP:2.957828
  • SMILES:[H][C@@]12[#6@H](-[#6]-[#6][C@@]1([#6])[C@]1([#6])[#6]-[#6][C@@]3([H])C([#6])([#6])[#6@H](-[#6]-[#6][C@]3([#6])[C@@]1([H])[#6]-[#6@H]2-[#8])-[#8]-[#6@@H]-1-[#8]-[#6@H](-[#6]-[#8])-[#6@@H](-[#8])-[#6@H](-[#8])-[#6@H]-1-[#8]-[#6@@H]-1-[#8]-[#6@H](-[#6]-[#8])-[#6@@H](-[#8])-[#6@H](-[#8])-[#6@H]-1-[#8])-[#6](=[#6])-[#6]-[#6]\[#6]=[#6](/[#6])-[#6]
    SMILES:[H][C@@]12[#6@H](-[#6]-[#6][C@@]1([#6])[C@]1([#6])[#6]-[#6][C@@]3([H])C([#6])([#6])[#6@H](-[#6]-[#6][C@]3([#6])[C@@]1([H])[#6]-[#6@H]2-[#8])-[#8]-[#6@@H]-1-[#8]-[#6@H](-[#6]-[#8])-[#6@@H](-[#8])-[#6@H](-[#8])-[#6@H]-1-[#8]-[#6@@H]-1-[#8]-[#6@H](-[#6]-[#8])-[#6@@H](-[#8])-[#6@H](-[#8])-[#6@H]-1-[#8])-[#6](=[#6])-[#6]-[#6]\[#6]=[#6](/[#6])-[#6]
  • Ginsenoside Rk1 (Standard) 是 Ginsenoside Rk1 的标准品。适用于定量分析、质量控制及生化实验等相关研究。Ginsenoside Rk1 是人参的高温加工提取物,抑制Jak2/Stat3信号通路和NF-κB 的激活。它具有抗肿瘤、抗血小板聚集活性、抗炎、抗胰岛素抵抗、肾保护和抗菌作用,可使认知功能增强,脂质积聚减少和预防骨质疏松症,还诱导细胞凋亡。
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    1-3天
    纯度
    98.46%
    ¥ 393.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~